| Ms Taylor Kue, PA | |
|
102 Valley Rd, Middletown, RI 02842-5237 | |
| (401) 239-1800 | |
| (401) 239-1791 |
| Full Name | Ms Taylor Kue |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 102 Valley Rd, Middletown, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326751348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA01669 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Taylor Kue, PA 102 Valley Rd, Middletown, RI 02842-5237 Ph: (401) 239-1800 | Ms Taylor Kue, PA 102 Valley Rd, Middletown, RI 02842-5237 Ph: (401) 239-1800 |
News Archive
MedeAnalytics, a leading provider of healthcare performance management solutions, announced its summer 2009 software platform release, MedeAnalytics 9, which offers performance-packed features for enhanced collaboration and personalization. Deployed to clients on Aug. 17, the release incorporates client input and reflects the company's ongoing investment in its analytic platform.
Like a beloved pair of jeans, human DNA accumulates damage over time, and older people's bodies can't repair it as well. Many scientists believe a build up of damage can cause cells to enter an irreversible dormant state known as senescence. Cellular senescence is believed to be responsible for some of the telltale signs of aging, such as weakened bones, less resilient skin and slow-downs in organ function.
Two independent teams of researchers have identified a role for enhanced activation of the signaling protein Notch in tumors characterized by inactivation of either the TSC1 or the TSC2 protein. As indicated by Warren Pear, at the University of Pennsylvania, Philadelphia, in an accompanying commentary, these data provide a rationale for testing whether Notch inhibitors are of benefit to those with TSC-associated tumors.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
› Verified 2 days ago
Amanda N Fredette, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 102 Valley Rd, Middletown, RI 02842 Phone: 401-239-1800 Fax: 401-239-1801 | |
Rebbecca Shea, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 102 Valley Rd, Middletown, RI 02842 Phone: 401-239-1800 Fax: 401-239-1801 | |
Kendra Ryan Pimenta, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 850 Aquidneck Ave, Middletown, RI 02842 Phone: 401-846-0055 Fax: 401-842-0963 | |
Erinn Michelle Seyler, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 102 Valley Rd, Middletown, RI 02842 Phone: 401-239-1800 Fax: 401-239-1791 | |
Ashlin Paige Brown, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 102 Valley Rd, Middletown, RI 02842 Phone: 401-239-1800 | |
Abigail Finkenauer, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 102 Valley Rd, Middletown, RI 02842 Phone: 401-239-1800 Fax: 401-239-1791 |